ArticleTanaffos2024
Effect of Chest Physiotherapy on the Clinical Outcomes of COVID-19 Patients.
Article in Tanaffos, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The novel coronavirus 2019 primarily affects the respiratory system and may lead to respiratory failure and the need for intubation. This study aimed to investigate the effect of chest physiotherapy on the clinical outcomes of patients with COVID-19. Materials and Methods: This randomized clinical trial was performed in 2022-2023. The research population included 58 patients with COVID-19 who were hospitalized at Izeh Shohada Hospital, Khuzestan. Patients in the control group received routine care, which included the use of supportive drugs based on the doctor's opinion, oxygen therapy, and nutritional support. The intervention group received chest physiotherapy and breathing exercises for six days. At the end of the third and sixth days, the patients of both groups were evaluated in terms of lung function, respiratory gases, and the length of hospital stay. Moreover, the need for intubation was recorded during study time. Data analysis was done using SPSS version 23 software. Results: In the intervention group, a significant improvement was observed in FVC (P<0.01), FEV Conclusion: The results showed that in the new crisis resulting from COVID-19, chest physiotherapy and respiratory exercises could be used as a helpful method in improving lung function, respiratory gases, and reducing the hospital stay in COVID-19 patients.
Indexed as
Identifiers
41018931PMC12464844What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.